Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA
- PMID: 35378384
- DOI: 10.1016/j.euroneuro.2022.03.006
Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA
Abstract
3,4-methylenedioxyamphetamine (MDA) is a psychoactive compound chemically related to the entactogen MDMA. MDA shares some of the entactogenic effects of MDMA but also exerts stimulant effects and psychedelic properties at higher doses. Here, we examined the pharmacological properties of MDA analogs and related amphetamine-based compounds detected in street drug samples or in sport supplements. We examined the key pharmacological mechanisms including monoamine uptake inhibition and release using human embryonic kidney 293 cells stably transfected with the respective human transporters. Additionally, we assessed monoamine transporter and receptor binding and activation properties. MDA, its fluorinated analogs, as well as the α-ethyl containing BDB and the dimeric amphetamine DPIA inhibited NET with the greatest potency and preferentially inhibited 5-HT vs. dopamine uptake. The β‑methoxy MDA analog 3C-BOH and the amphetamine-based N,α-DEPEA inhibited NET and preferentially inhibited dopamine vs. 5-HT uptake. The test drugs mediated efflux of at least one monoamine with the exception of DPIA. Most compounds bound to 5-HT2A and 5-HT2C receptors (Ki ≤ 10 µM) and several substances activated the 5-HT2A and 5-HT2B receptor as partial or full agonists. Furthermore, several compounds interacted with adrenergic receptors and the trace amine-associated receptor 1 (TAAR1) in the micromolar range. The pharmacological profiles of some fluorinated and nonfluorinated MDA analogs resemble the profile of MDMA. In contrast, 3C-BOH and N,α-DEPEA displayed more pronounced dopaminergic activity similar to amphetamine. Pharmacokinetics and pharmacodynamics studies are necessary to better establish the risks and therapeutic potential of the tested drugs.
Keywords: MDA; amphetamine; dopamine; new psychoactive substances; serotonin; transporter.
Copyright © 2022. Published by Elsevier B.V.
Conflict of interest statement
Conflict of interest D.T. is an employee of ReseaChem GmbH and M.C.H. is an employee of F. Hoffmann-La Roche. M.E.L. is a consultant for Mind Medicine, Inc. The other authors declare no competing interests.
Similar articles
-
Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.Handb Exp Pharmacol. 2018;252:143-164. doi: 10.1007/164_2018_113. Handb Exp Pharmacol. 2018. PMID: 29633178 Review.
-
Pharmacological profile of novel psychoactive benzofurans.Br J Pharmacol. 2015 Jul;172(13):3412-25. doi: 10.1111/bph.13128. Epub 2015 Apr 24. Br J Pharmacol. 2015. PMID: 25765500 Free PMC article.
-
Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.Eur Neuropsychopharmacol. 2015 Mar;25(3):365-76. doi: 10.1016/j.euroneuro.2014.12.012. Epub 2015 Jan 5. Eur Neuropsychopharmacol. 2015. PMID: 25624004
-
Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.Pharmacol Biochem Behav. 2008 Aug;90(2):198-207. doi: 10.1016/j.pbb.2007.10.003. Epub 2007 Oct 16. Pharmacol Biochem Behav. 2008. PMID: 18035407 Free PMC article. Review.
-
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.Biochem Pharmacol. 1987 Jul 15;36(14):2297-303. doi: 10.1016/0006-2952(87)90594-6. Biochem Pharmacol. 1987. PMID: 2886126
Cited by
-
Interpol Review of Drug Analysis 2019-2022.Forensic Sci Int Synerg. 2023 Jan 5;6:100299. doi: 10.1016/j.fsisyn.2022.100299. eCollection 2023. Forensic Sci Int Synerg. 2023. PMID: 36655023 Free PMC article. Review. No abstract available.
-
The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.Neurochem Res. 2023 Apr;48(4):1129-1166. doi: 10.1007/s11064-022-03772-0. Epub 2022 Nov 3. Neurochem Res. 2023. PMID: 36327017 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical